$LASE
Laser Photonics Corp Stock $lase

$lase Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224046462 Filed on November 18, 2024

Income Statement

Concept	2024 Q3	2023 Q3
Revenue	$669.2K	$1.240M
YoY Change	-46.01%	1.23%
Cost Of Revenue	$107.3K	$333.3K
YoY Change	-67.82%	-35.05%
Gross Profit	$609.4K	$906.2K
YoY Change	-32.75%	27.41%
Gross Profit Margin	91.07%	73.11%
Selling, General & Admin	$1.608M	$1.850M
YoY Change	-13.11%	365.49%
% of Gross Profit	263.82%	204.19%
Research & Development	$62.80K	$75.43K
YoY Change	-16.74%
% of Gross Profit	10.31%	8.32%
Depreciation & Amortization	$238.6K	$86.17K
YoY Change	176.93%	1.55%
% of Gross Profit	39.16%	9.51%
Operating Expenses	$2.315M	$2.003M
YoY Change	15.61%	315.16%
Operating Profit	-$1.706M	-$1.096M
YoY Change	55.59%	-578.95%
Interest Expense		$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$80.63K	$0.00
YoY Change
Pretax Income	-$1.625M	-$1.096M
YoY Change	48.24%	-600.83%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.625M	-$1.096M
YoY Change	48.24%	-634.6%
Net Earnings / Revenue	-242.87%	-88.45%
Basic Earnings Per Share	-$0.13	-$0.13
Diluted Earnings Per Share	-$0.13	-$0.13
COMMON SHARES
Basic Shares Outstanding	12.27M shares	8.253M shares
Diluted Shares Outstanding	12.67M shares	7.878M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.122M	$8.311M
YoY Change	-74.47%	3482.28%
Cash & Equivalents	$2.122M	$8.311M
Short-Term Investments
Other Short-Term Assets	$40.79K	$66.94K
YoY Change	-39.07%
Inventory	$1.831M	$2.610M
Prepaid Expenses
Receivables	$773.3K	$1.656M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.767M	$12.64M
YoY Change	-62.3%	299.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.258M	$760.6K
YoY Change	65.46%	22.86%
Goodwill
YoY Change
Intangibles	$4.027M
YoY Change
Long-Term Investments	$316.4K
YoY Change
Other Assets		$66.94K
YoY Change		533.26%
Total Long-Term Assets	$5.854M	$4.145M
YoY Change	41.25%	3.69%
TOTAL ASSETS
Total Short-Term Assets	$4.767M	$12.64M
Total Long-Term Assets	$5.854M	$4.145M
Total Assets	$10.62M	$16.79M
YoY Change	-36.74%	134.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$533.9K	$233.3K
YoY Change	128.84%	17.66%
Accrued Expenses	$30.08K	$352.4K
YoY Change	-91.46%	81.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$886.8K	$585.7K
YoY Change	51.42%	17.68%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$46.35K	$236.1K
YoY Change	-80.37%	20.47%
Total Long-Term Liabilities	$46.35K	$236.1K
YoY Change	-80.37%	20.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$886.8K	$585.7K
Total Long-Term Liabilities	$46.35K	$236.1K
Total Liabilities	$933.1K	$821.8K
YoY Change	13.55%	18.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.341M	-$3.228M
YoY Change	158.42%	-374.86%
Common Stock	$13.83K	$82.53K
YoY Change	-83.24%	69.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$25.24K
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.688M	$15.97M
YoY Change
Total Liabilities & Shareholders Equity	$10.62M	$16.79M
YoY Change	-36.74%	134.49%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.625M	-$1.096M
YoY Change	48.24%	-634.6%
Depreciation, Depletion And Amortization	$238.6K	$86.17K
YoY Change	176.93%	1.55%
Cash From Operating Activities	-$3.189M	-$395.7K
YoY Change	706.0%	10.0%
INVESTING ACTIVITIES
Capital Expenditures	$88.88K	$135.6K
YoY Change	-34.44%	-4501.95%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$88.88K	-$135.6K
YoY Change	-34.44%	4301.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.652M	-1.050M
YoY Change	-352.6%	-2019.21%
NET CHANGE
Cash From Operating Activities	-3.189M	-395.7K
Cash From Investing Activities	-88.88K	-135.6K
Cash From Financing Activities	2.652M	-1.050M
Net Change In Cash	-625.9K	-1.581M
YoY Change	-60.42%	413.22%
FREE CASH FLOW
Cash From Operating Activities	-$3.189M	-$395.7K
Capital Expenditures	$88.88K	$135.6K
Free Cash Flow	-$3.278M	-$531.3K
YoY Change	517.04%	48.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41515
	dei	Entity Registrant Name EntityRegistrantName	Laser Photonics Corporation
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2121760	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6201137	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001807887
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment		usd
CY2023Q3	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment		usd
	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment		usd
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q3	LASE	Inventory Sales Demo InventorySalesDemo		usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3628771
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1101 N. Keller Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite G
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32810
	dei	City Area Code CityAreaCode	(407)
	dei	Local Phone Number LocalPhoneNumber	804 1000
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	LASE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13832395	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q3	us-gaap	Inventory Net InventoryNet	1830725	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2237455	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	40788	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	39190	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	4766568	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9294146	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1258488	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4026820	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4279987	usd
CY2024Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	316378	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	252558	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2024Q3	us-gaap	Assets Assets	10620812	usd
CY2023Q4	us-gaap	Assets Assets	15124087	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	116564	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213114	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	206212	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434152	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30083	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	161538	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	886798	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1031844	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46346	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162991	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	46346	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	162991	usd
CY2024Q3	us-gaap	Liabilities Liabilities	933144	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1194835	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13832395	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9253419	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13807460	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9228482	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	13832	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	9253	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18039795	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19180725	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8340719	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5235486	usd
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	25240	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	25240	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9687668	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13929252	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10620812	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15124087	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	669182	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1303205	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2083123	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2944837	usd
CY2024Q3	LASE	Revenue From Contract With Customer Excluding Assessed Tax For Affiliate RevenueFromContractWithCustomerExcludingAssessedTaxForAffiliate	47515	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	107277	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	333325	usd
	us-gaap	Cost Of Revenue CostOfRevenue	772481	usd
	us-gaap	Cost Of Revenue CostOfRevenue	887086	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	609420	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	969880	usd
	us-gaap	Gross Profit GrossProfit	1310642	usd
	us-gaap	Gross Profit GrossProfit	2057751	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	554667	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	677026	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	957558	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1462868	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1053124	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	608647	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1845167	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1936521	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	238617	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	152210	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	669827	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	336294	usd
CY2024Q3	us-gaap	Salaries And Wages SalariesAndWages	406107	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	347461	usd
	us-gaap	Salaries And Wages SalariesAndWages	853264	usd
	us-gaap	Salaries And Wages SalariesAndWages	993572	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62802	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75430	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	170725	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	155889	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2315317	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1860774	usd
	us-gaap	Operating Expenses OperatingExpenses	4496541	usd
	us-gaap	Operating Expenses OperatingExpenses	4885144	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1705897	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-890894	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3185899	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2827393	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80629	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4215	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80666	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4215	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1625268	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-895109	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3105233	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2831608	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1625268	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-895109	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3105233	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2831608	usd
	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment	6615000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1625268	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-895109	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9720233	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2831608	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.13
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.90
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.90
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.36
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.36
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12671166	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12671166	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7878419	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7878419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10847009	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10847009	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7878419	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7878419	shares
	us-gaap	Net Income Loss NetIncomeLoss	-3105233	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2831608	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	208351	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	33336	usd
	LASE	Distribution To Affiliate DistributionToAffiliate	3822037	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	669827	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	336294	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	165282	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36083	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26979	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	640180	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15976	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5591	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	106	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	311874	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	30034	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-132431	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-338605	usd
	LASE	Increase Decrease In Deposit IncreaseDecreaseInDeposit	-302000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-96549	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6443099	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3474451	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	57550	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	124833	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	5295	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	144096	usd
	LASE	Payments To Acquire Licenses And Patents PaymentsToAcquireLicensesAndPatents	2875	usd
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	34069	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	225783	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	19707	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-288628	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-325580	usd
	LASE	Corrections Of Stock Compensation CorrectionsOfStockCompensation	71250	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2652350	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2652350	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-71250	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4079377	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3871281	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6201137	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2121760	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8310518	usd
	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense	6615000	usd
	LASE	Common Stock To Be Issued For Cashless Exercise Of Warrants CommonStockToBeIssuedForCashlessExerciseOfWarrants	62	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10283629	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1625268	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1623043	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2652350	usd
CY2024Q3	LASE	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	0	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9687668	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15194989	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-895109	usd
CY2023Q3	LASE	Correction Of Stock Compensation Related Errors CorrectionOfStockCompensationRelatedErrors	-71250	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	14228630	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13929252	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3105233	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3822037	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	33336	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	6615000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	6615000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2652350	usd
	LASE	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	0	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9687668	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131488	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2831608	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2831608	usd
	LASE	Correction Of Stock Compensation Related Errors CorrectionOfStockCompensationRelatedErrors	71250	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	14228630	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	14228630	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2944837	usd
	us-gaap	Cost Of Revenue CostOfRevenue	887086	usd
	us-gaap	Gross Profit GrossProfit	2057751	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1462868	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1936521	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	336294	usd
	us-gaap	Salaries And Wages SalariesAndWages	993572	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	155889	usd
	us-gaap	Operating Expenses OperatingExpenses	4885144	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2827393	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4215	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2831608	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2831608	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Net Income Loss NetIncomeLoss	-2831608	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	336294	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36083	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	640180	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5591	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	106	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	30034	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-338605	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3474451	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	124833	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	144096	usd
	LASE	Payments For Licenses Patents PaymentsForLicensesPatents	2875	usd
	LASE	Proceeds From Leashold Improvments ProceedsFromLeasholdImprovments	-19707	usd
	us-gaap	Payments For Software PaymentsForSoftware	34069	usd
	LASE	Payments To Long Term Assets PaymentsToLongTermAssets	-0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-325580	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	LASE	Proceeds From Repayments Of Additional Paid In Capital ProceedsFromRepaymentsOfAdditionalPaidInCapital	-71250	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-71250	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3871281	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8310518	usd
	LASE	Common Stock Issued To Pay Compensation For Marketing CommonStockIssuedToPayCompensationForMarketing	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1303205	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	333325	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	969880	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	677026	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	608647	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	152210	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	347461	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75430	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1860774	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-890894	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4215	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-895109	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-895109	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2024Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	533938	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	223040	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	116564	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213114	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	981266	usd
CY2024Q3	LASE	Allowance Estimated Credit Losses AllowanceEstimatedCreditLosses	207971	usd
CY2024Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	969356	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	862940	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	908327	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	992744	usd
CY2023Q4	LASE	Inventory Sales Demo InventorySalesDemo	162958.00	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	234226	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	243029	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	281184	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24216	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	1830725	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2237455	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1146616	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	729956	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1258488	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	978395	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	725228	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4026820	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4279987	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	132819	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	91062	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	292513	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	272733	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13832395	shares
CY2024Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3000000.0	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.34
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1683867	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	61968	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2024Q3	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	626918	shares
CY2022Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	4688695	shares
CY2021Q4	us-gaap	Area Of Land AreaOfLand	18000
CY2021Q4	us-gaap	Variable Lease Payment VariableLeasePayment	15109	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	8000
CY2023Q4	us-gaap	Variable Lease Payment VariableLeasePayment	10000	usd
CY2021Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25109	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	8000
CY2022Q4	us-gaap	Variable Lease Payment VariableLeasePayment	14805	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434153	usd
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162990	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	252558	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	206212	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46346	usd
CY2024Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	93553	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	159005	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	252558	usd

Files In Submission

Name	View Source	Status
0001493152-24-046462-index-headers.html	Edgar Link	pending
0001493152-24-046462-index.html	Edgar Link	pending
0001493152-24-046462.txt	Edgar Link	pending
0001493152-24-046462-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lase-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
lase-20240930_cal.xml	Edgar Link	unprocessable
lase-20240930_def.xml	Edgar Link	unprocessable
lase-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lase-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LASE
Laser Photonics Corp Stock $lase

2024 Q3 Form 10-Q Financial Statement

#000149315224046462 Filed on November 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE Laser Photonics Corp Stock $lase

2024 Q3 Form 10-Q Financial Statement

#000149315224046462 Filed on November 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE
Laser Photonics Corp Stock $lase